Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
+486K
-
Total reported value, excl. options
-
$128M
-
Value change
-
-$1.44M
-
Number of buys
-
29
-
Number of sells
-
-35
-
Price
-
$6.53
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q1 2022
81 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q1 2022.
Apyx Medical Corp - Common Stock (APYX) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 35M outstanding shares and own 55.95% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.4M shares), COWEN AND COMPANY, LLC (2.63M shares), Archon Capital Management LLC (2.33M shares), BlackRock Inc. (1.97M shares), VANGUARD GROUP INC (1.56M shares), PURA VIDA INVESTMENTS, LLC (983K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), STATE STREET CORP (558K shares), DIMENSIONAL FUND ADVISORS LP (527K shares), and RENAISSANCE TECHNOLOGIES LLC (512K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.